Vancomycin Minimum Inhibitory Concentration Is Not a Substitute for Clinical Judgment: Response to Healthcare-Associated Ventriculitis and Meningitis.

about

Reply to Marx et al.

P2860

Q42019012-9150D8E3-CD6C-4281-AFF0-820BF91E86D3

P2860

Vancomycin Minimum Inhibitory Concentration Is Not a Substitute for Clinical Judgment: Response to Healthcare-Associated Ventriculitis and Meningitis.

Item

http://www.wikidata.org/entity/Q41987746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Vancomycin Minimum Inhibitory ...... Ventriculitis and Meningitis.

@en

type

Item

label

Vancomycin Minimum Inhibitory ...... Ventriculitis and Meningitis.

@en

prefLabel

Vancomycin Minimum Inhibitory ...... Ventriculitis and Meningitis.

@en

P1476

Vancomycin Minimum Inhibitory ...... Ventriculitis and Meningitis.

@en

P2093

Ashley Marx

http://www.w3.org/2001/XMLSchema#string

David J Weber

http://www.w3.org/2001/XMLSchema#string

Lindsay Daniels

http://www.w3.org/2001/XMLSchema#string

Melissa B Miller

http://www.w3.org/2001/XMLSchema#string

P2860

2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods.

Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus.

Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus.

Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used.

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

P304

1428-1429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIX552

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29017241

http://www.w3.org/2001/XMLSchema#string

P921

meningitis

Vancomycin Minimum Inhibitory Concentration Is Not a Substitute for Clinical Judgment: Response to Healthcare-Associated Ventriculitis and Meningitis.

about

P2860

P2860

Vancomycin Minimum Inhibitory Concentration Is Not a Substitute for Clinical Judgment: Response to Healthcare-Associated Ventriculitis and Meningitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921